Richard Benarous

Nessuna posizione attualmente

Health Technology

Finance

Profilo

Richard Benarous is the founder of two companies.
In 2000, he founded Cytomics Pharmaceuticals SA. In 2006, he founded CellVir SAS and held the title of Chief Technology Officer in 2009.
Dr. Benarous was also a Professor at the Massachusetts Institute of Technology.

Precedenti posizioni note di Richard Benarous

Società	Posizione	Fine
CellVir SAS CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France.	Fondatore	04/06/2012
Cytomics Pharmaceuticals SA Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation.	Fondatore	10/10/2011
Massachusetts Institute of Technology	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Richard Benarous

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Richard Benarous

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Cytomics Pharmaceuticals SA Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation.	Health Technology
CellVir SAS CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France.	Health Technology